Moody’s downgrades Monroe Clinic to ‘Baa1’

Moody’s Investors Service downgraded Monroe (Wis.) Clinic’s series 2016 revenue refunding bonds from “A3” to “Baa1,” affecting $41 million of debt.

Advertisement

The downgrade is a result of several factors, including the clinic’s weak operating performance, increased capital spending and physician turnover rates. Moody’s also acknowledged the hospital’s strong market position, favorable liquidity metrics and light debt burden.

The outlook is stable, reflecting Moody’s expectation that Monroe Clinic will keep its leading market position and liquidity measures intact. 

More articles on healthcare finance:
Lurie Children’s Hospital receives $3.5M from Chicago Cubs first baseman
How a critical access hospital bounced back from the brink of bankruptcy: 5 questions with Carthage Area Hospital CFO Rob Bloom
Cheyenne Regional Medical Center no longer at risk of losing CMS contract

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.